Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 16(18): 1771-4, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9778755

RESUMO

Despite vaccination, influenza remains a common of morbidity in nursing homes. Chemoprophylaxis of residents with currently available antivirals is not always effective and new agents effective against both influenza A and B are needed. In a randomized, unblinded pilot study, we compared 14 day chemoprophylaxis with zanamivir, an antiviral which inhibits influenza neuraminidase, to standard of care during sequential influenza A and influenza B outbreaks in a 735 bed nursing home. Influenza A outbreaks were declared on 6/14 epidemic units. Sixty-five volunteers on four epidemic units were randomized to zanamivir and on two epidemic units, 23 volunteers were randomized to rimantadine. During the 14 days of prophylaxis, only four new febrile respiratory illnesses were detected. One volunteer receiving rimantadine prophylaxis developed laboratory-confirmed influenza. Influenza B outbreaks were declared on 3/14 epidemic units. Thirty-five volunteers on two epidemic units were randomized to zanamivir and 18 volunteers on one epidemic unit were randomized to no drug. During the 14 days of prophylaxis, only one new febrile respiratory illness was detected. One volunteer randomized to receive no drug developed laboratory-confirmed influenza. Zanamivir appears comparably effective to standard of care in preventing influenza-like illness and laboratory-confirmed influenza in nursing homes, but requires further testing.


Assuntos
Antivirais/uso terapêutico , Surtos de Doenças/prevenção & controle , Influenza Humana/prevenção & controle , Casas de Saúde , Ácidos Siálicos/uso terapêutico , Idoso , Feminino , Guanidinas , Humanos , Vírus da Influenza A , Vírus da Influenza B , Influenza Humana/epidemiologia , Masculino , Estudos Prospectivos , Piranos , Distribuição Aleatória , Rimantadina/uso terapêutico , Resultado do Tratamento , Wisconsin/epidemiologia , Zanamivir
2.
J Clin Monit ; 8(2): 126-30, 1992 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1583548

RESUMO

Although hyperventilation with hypocapnia is frequently used in the management of neurosurgical patients in whom sensory-evoked potentials may be monitored, the effects of hypocapnia on evoked potentials have not been described with precision. In the present experiment, the effects of randomized arterial carbon dioxide tensions of 20, 25, 30, and 35 mm Hg on spinal, subcortical, and cortical somatosensory-evoked potentials (SEPs) were measured in dogs anesthetized with 1.40% isoflurane. Other variables known to affect the SEP (temperature, blood pressure, and arterial oxygen tension) were stable throughout the experiment. Hypocapnia caused reductions in the latencies of the early peaks of the spinal and subcortical SEPs. These differences were small, consisting of a 2% shortening of latency at 20 mm Hg carbon dioxide tension when compared with 35 mm Hg. No changes were detected in the later subcortical and cortical latencies. SEP amplitudes were also unchanged. These results in a controlled animal study corroborate the direction and magnitude of changes due to hypocapnia observed by other investigators in surgical patients. The magnitude of the changes indicates that SEP monitoring sensitivity is not compromised by clinically useful levels of induced hypocapnia during isoflurane anesthesia. Because hypocapnia may produce small SEP changes, baseline recordings should be acquired prior to initiation of hyperventilation. It is not warranted, however, to impute a severe deterioration of the SEP to hypocapnia alone, and causes must be sought elsewhere in a patient's status and management.


Assuntos
Anestesia por Inalação , Córtex Cerebral/fisiopatologia , Potenciais Somatossensoriais Evocados/fisiologia , Hipocapnia/fisiopatologia , Isoflurano , Medula Espinal/fisiopatologia , Análise de Variância , Animais , Dióxido de Carbono/sangue , Cães , Estimulação Elétrica , Hipocapnia/sangue , Hipocapnia/epidemiologia , Pressão Parcial
3.
Electroencephalogr Clin Neurophysiol ; 69(3): 277-86, 1988 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2450008

RESUMO

Evidence that canine spinal, far-field and near-field somatosensory evoked potentials resemble those recorded in humans and other species has been presented, and the vulnerability of each component to varying depths of halothane anesthesia is reported. Lumbar spinal peak latencies are not affected by halothane dose, but the negative peak is significantly prolonged by rapid rates of stimulation. Elevated stimulus rates and halothane doses reduce lumbar spinal cord potential amplitudes. Early far-field cephalic components are refractory to halothane. Late far-field components and near-field cortical potentials are substantially altered by increments in halothane dose. Both near-field and far-field responses are more readily identified in vertex-neck than vertex-brow derivations. Early far-field somatosensory evoked potentials recorded from vertex to neck, together with lumbar spinal cord potentials, may be the preferred monitoring technique when the use of halothane anesthesia is desired. Rapid rates of stimulation may facilitate earlier recognition of cord dysfunction, but supplement rather than replace baseline recordings at slow stimulus rates.


Assuntos
Cães/fisiologia , Potenciais Somatossensoriais Evocados/efeitos dos fármacos , Halotano/farmacologia , Medula Espinal/fisiologia , Animais , Relação Dose-Resposta a Droga , Estimulação Elétrica , Região Lombossacral , Pescoço , Tempo de Reação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...